Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242339 (
dyslipidemia
)
13,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis. Melanoma inhibitor protein 3 (
MIA3
) is required for the export of collagen VlI (COL7A1) from the endoplasmic reticulum and it appears to be a tumor suppressor of malignant melanoma. Genome-wide association studies have described an association between
MIA3
rs17465637 A/C polymorphisms and coronary artery disease and myocardial infarction. Because of that, we assessed the
MIA3
rs17465637 polymorphism in 1505 RA Spanish patients stratified according to the presence/absence of cardiovascular (CV) disease. Also, a subgroup of patients without CV events was assessed for the presence of subclinical atherosclerosis using carotid ultrasound to establish carotid intima-media wall thickness and carotid plaques and brachial ultrasonography to determine the presence of endothelial dysfunction by flow-mediated endothelium-dependent and independent vasodilatation.
MIA3
rs17465637 allele A showed a trend for association with the presence of carotid plaques (odds ratio 1.56, 95% confidence interval [0.96-2.51]; p=0.07). However, apart from an association of the
MIA3
rs17465637 A allele with the risk of CV events in RA patients with
dyslipidemia
(p=0.018), no other significant associations were found between the presence of
MIA3
rs17465637 A allele and the risk of suffering CV events or other surrogate markers of atherosclerosis. In conclusion, our results suggest a potential association of the
MIA3
rs17465637 with CV disease in dyslipidemic patients with RA. However, additional studies are required to better establish the role of the
MIA3
gene in mechanisms leading to the accelerated atherogenesis observed in RA.
...
PMID:Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients. 2257 32